3-86969120-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_016206.4(VGLL3):​c.407G>A​(p.Ser136Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000506 in 1,579,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000042 ( 0 hom. )

Consequence

VGLL3
NM_016206.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.70
Variant links:
Genes affected
VGLL3 (HGNC:24327): (vestigial like family member 3) Predicted to enable protein C-terminus binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057382703).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VGLL3NM_016206.4 linkuse as main transcriptc.407G>A p.Ser136Asn missense_variant 3/4 ENST00000398399.7
VGLL3NM_001320493.2 linkuse as main transcriptc.407G>A p.Ser136Asn missense_variant 3/4
VGLL3NM_001320494.2 linkuse as main transcriptc.248G>A p.Ser83Asn missense_variant 3/4
VGLL3XM_006713138.5 linkuse as main transcriptc.404G>A p.Ser135Asn missense_variant 3/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VGLL3ENST00000398399.7 linkuse as main transcriptc.407G>A p.Ser136Asn missense_variant 3/41 NM_016206.4 P1A8MV65-1
VGLL3ENST00000383698.3 linkuse as main transcriptc.407G>A p.Ser136Asn missense_variant 3/41 A8MV65-2
VGLL3ENST00000494229.1 linkuse as main transcriptc.209G>A p.Ser70Asn missense_variant 3/33

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000227
AC:
5
AN:
219916
Hom.:
0
AF XY:
0.0000334
AC XY:
4
AN XY:
119828
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000294
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000420
AC:
6
AN:
1427498
Hom.:
0
Cov.:
31
AF XY:
0.00000566
AC XY:
4
AN XY:
706614
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000127
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000170
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152172
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000385
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113
ExAC
AF:
0.0000249
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 27, 2023The c.407G>A (p.S136N) alteration is located in exon 3 (coding exon 3) of the VGLL3 gene. This alteration results from a G to A substitution at nucleotide position 407, causing the serine (S) at amino acid position 136 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.018
T;.
Eigen
Benign
-0.064
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.48
T;T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.057
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N;N
MutationTaster
Benign
0.99
D;D
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.11
N;N
REVEL
Benign
0.066
Sift
Benign
0.34
T;T
Sift4G
Benign
0.46
T;T
Polyphen
0.044
B;.
Vest4
0.18
MutPred
0.29
Gain of glycosylation at S136 (P = 0.007);Gain of glycosylation at S136 (P = 0.007);
MVP
0.28
MPC
0.14
ClinPred
0.12
T
GERP RS
5.9
Varity_R
0.065
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751239304; hg19: chr3-87018270; API